NCT01251874 2025-11-21
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT02608216 2025-09-03
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
University of Pennsylvania
Phase 1 Active not recruiting
NCT01928186 2018-05-15
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
University of Washington
Phase NA Completed
NCT01222416 2017-07-02
PET/CT Evaluation of Treatment Response in Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT00572728 2016-12-30
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01480583 2016-07-13
GRABM-B
Angiochem Inc
Phase 2 Completed
NCT00534274 2014-12-16
Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy
UNICANCER
Phase NA Completed
NCT01713049 2012-10-24
18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound
National Taiwan University Hospital
Phase NA Unknown